The role of CD24 as a potential biomarker for malignant pleural mesothelioma
Egyptian Journal of Chest Disease and Tuberculosis, 2023 Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa +4 more
doaj +1 more source
Diagnostic Role of Angiopoietin-2 and Vascular Endothelial Growth Factor in Malignant Pleural Effusion [PDF]
Zagazig University Medical Journal, 2020 Background Malignant pleural effusion is a prognostic and diagnostic sign in cancer lung .Role of tumor biomarkers in pleural fluid has been considered, but their diagnostic ability remains undetermined, therefore the aim of this current work is to ...
Doaa Gad +2 more
doaj +1 more source
The Significance of BRCA-associated Protein (BAP1) and Calretinin Expression in Malignant Pleural Mesothelioma and Non-small Cell Lung Carcinoma: An Immunohistochemical Study [PDF]
Zagazig University Medical Journal, 2019 Background: Malignant pleural mesothelioma (MPM) and non-small cell lung carcinoma (NSCLC) are common diseases with rising incidence, patients have different prognosis and are treated differently, and thus it is very important to diagnose these ...
Amira Salem +3 more
doaj +1 more source
Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
Diagnostics, 2022 Malignant pleural mesothelioma is a rare cancer characterized by a very poor prognosis. Exposure to asbestos is the leading cause of malignant pleural mesothelioma.
Jacopo Moro +13 more
doaj +1 more source
Biomedicines, 2022 Malignant pleural mesothelioma is an aggressive malignancy with poor prognosis. Unilateral pleural effusion is frequently the initial clinical sign requiring therapeutic thoracentesis, which also offers a diagnostic opportunity.
Lorenzo Zallocco +8 more
doaj +1 more source
Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis
Frontiers in Oncology, 2022 Malignant pleural mesothelioma is an uncommon aggressive tumor. Its incidence is even lower when the lung parenchyma is the primary site. Myositis is a common paraneoplastic syndrome, but it rarely presents with malignant pleural mesothelioma.
Dandan Gong, Jian Yu, Xiaodong Jiang
doaj +1 more source
Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
Thoracic Cancer, 2020 Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi +6 more
doaj +1 more source
Role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma
Egyptian Journal of Chest Disease and Tuberculosis, 2015 Aim of the work: To evaluate the role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma by detecting its level in the pleural fluid and serum of the patient with malignant pleural mesothelioma in comparison with other causes of ...
Rehab El Sayed +4 more
doaj +1 more source
Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma
Case Reports in Nephrology, 2022 Malignant pleural mesothelioma is rarely associated with nephrotic syndrome. Cryoglobulinemia is found in various pathological statuses, such as hepatitis C virus infection but rarely in malignant neoplasms.
Kei Nagai +3 more
doaj +1 more source
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
European Respiratory Review, 2016 Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in the ...
Anna C. Bibby +7 more
doaj +1 more source